Department of Ophthalmology and Visual Science, Escola Paulista de Medicina, Hospital São Paulo, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Department of Medicine, Discipline of Infectious and Parasitic Diseases, Escola Paulista de Medicina, Hospital São Paulo, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Arq Bras Oftalmol. 2023 Apr 3;87(5):e20220172. doi: 10.5935/0004-2749.2022-0172. eCollection 2023.
This study aimed to evaluate the pre-sence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in the ocular surface of individuals clinically suspected of coronavirus disease 2019 (COVID-19) and determine the accuracy of different approaches of molecular testing on the ocular surface based on the nasopharyngeal positivity status for COVID-19.
A total of 152 individuals with suspected COVID-19 symptoms who simultaneously underwent nasopharyngeal and two different tear film collection techniques for quantitative reverse-transcriptase polymerase chain reaction (RT-qPCR) were included. Tears were collected and randomized: one eye had the filter strip for the Schirmer test and the contralateral eye had conjunctival swab/cytology in the inferior fornix. All patients underwent slit lamp biomicroscopy. The accuracy of various ocular surface collection techniques used for the detection of SARS-CoV-2 RNA was determined.
Of the 152 patients enrolled in the study, 86 (56.6%) had COVID-19 confirmed by nasopharyngeal PCR. Both tear film collection techniques detected viral particles: the Schirmer test was positive in 16.3% (14/86) and the conjunctival swab/cytology in 17.4% (15/86), with no statistically significant differences. No positive ocular tests were found among those with negative nasopharyngeal PCR tests. The overall agreement of the ocular tests was 92.7%, and in combination, the sensitivity would increase to 23.2%. The mean cycle threshold values in the nasopharyngeal, Schirmer, and conjunctival swab/cytology tests were 18.2 ± 5.3, 35.6 ± 1.4, and 36.4 ± 3.9, respectively. Compared with the nasopharyngeal test, the Schirmer (p=0.001) and conjunctival swab/cytology (p<0.001) tests had significantly different Ct values.
The Schirmer (16.3%) and conjunctival swab (17.4%) tests were comparably capable of detecting SARS-CoV-2 RNA in the ocular surface by RT-PCR accurately based on nasopharyngeal status and demonstrated indistinct sensitivity and specificity. Simultaneous specimen sampling and processing from the nasopharyngeal, Schirmer, and conjunctival swab/cytology tests demonstrated significantly lower viral load in both ocular surface approaches than in the nasopharyngeal test. Ocular manifestations detected by slit lamp biomicroscopy were not associated with ocular RT-PCR positivity.
本研究旨在评估临床疑似 2019 年冠状病毒病(COVID-19)个体的眼表是否存在严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)RNA,并根据 COVID-19 鼻咽拭子阳性状态确定基于眼表的不同分子检测方法的准确性。
共纳入 152 例疑似 COVID-19 症状患者,同时进行鼻咽和两种不同的泪膜采集技术进行定量逆转录聚合酶链反应(RT-qPCR)。采集眼泪并随机分配:一只眼睛有用于 Schirmer 测试的滤纸条,另一只眼睛在下穹隆有结膜拭子/细胞学。所有患者均行裂隙灯生物显微镜检查。确定用于检测 SARS-CoV-2 RNA 的各种眼表采集技术的准确性。
在纳入研究的 152 例患者中,86 例(56.6%)经鼻咽 PCR 确诊 COVID-19。两种泪膜采集技术均检测到病毒颗粒:Schirmer 测试阳性率为 16.3%(14/86),结膜拭子/细胞学阳性率为 17.4%(15/86),差异无统计学意义。鼻咽 PCR 检测阴性者未发现眼部检测阳性。眼部检测的总一致性为 92.7%,联合检测时敏感性可提高至 23.2%。鼻咽、Schirmer 和结膜拭子/细胞学检测的平均循环阈值分别为 18.2±5.3、35.6±1.4 和 36.4±3.9。与鼻咽检测相比,Schirmer(p=0.001)和结膜拭子/细胞学(p<0.001)检测的 Ct 值有显著差异。
Schirmer(16.3%)和结膜拭子(17.4%)检测均可根据鼻咽状态准确检测眼表的 SARS-CoV-2 RNA,且具有相似的敏感性和特异性。同时采集鼻咽、Schirmer 和结膜拭子/细胞学标本并进行处理,两种眼表方法的病毒载量均显著低于鼻咽检测。裂隙灯生物显微镜检查检测到的眼部表现与眼部 RT-PCR 阳性无关。